Marie‐Ange Demoitié
GlaxoSmithKline (Belgium)(BE)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, HIV Research and Treatment, Malaria Research and Control, vaccines and immunoinformatics approaches, Mosquito-borne diseases and control
Most-Cited Works
- → Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial(2004)748 cited
- → Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis(2019)569 cited
- → Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age(2008)412 cited
- → Phase 2b Controlled Trial of M72/AS01 E Vaccine to Prevent Tuberculosis(2018)397 cited
- → Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial(2007)276 cited
- → HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy(1999)237 cited
- → A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals(1999)210 cited
- → Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial(2012)157 cited
- → Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area(2009)142 cited
- → Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting(2015)138 cited